For PFS, high expression of HSP90AA1 in BLCA, LIHC and LUAD had unfavorable prognosis but KIRC patients with higher expression of HSP90AA1 indicated better prognosis (Figure 5A). Here, HSP90AA1 is linked to bladder transitional cell carcinoma.